Water-Insoluble Drug Formulation
Herausgeber: Liu, Ron
Water-Insoluble Drug Formulation
Herausgeber: Liu, Ron
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Water-Insoluble Drug Formulation, Third Edition serves as a comprehensive reference for pharmaceutical scientists in the handling of formulation issues related to water-insoluble drugs.
Andere Kunden interessierten sich auch für
- Jean-Maurice VergnaudControlled Drug Release of Oral Dosage Forms421,99 €
- E M Kolassa (Mick)Pharmaceutical Marketing138,99 €
- Phage Display in Biotechnology and Drug Discovery276,99 €
- Cancer Targeting Therapies105,99 €
- Cherng-Ju KimAdvanced Pharmaceutics344,99 €
- Proteins and Peptides233,99 €
- Robert C. JacksonComputer Techniques in Preclinical and Clinical Drug Development233,99 €
-
-
-
Water-Insoluble Drug Formulation, Third Edition serves as a comprehensive reference for pharmaceutical scientists in the handling of formulation issues related to water-insoluble drugs.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis Ltd (Sales)
- 3rd edition
- Seitenzahl: 736
- Erscheinungstermin: 16. März 2018
- Englisch
- Abmessung: 254mm x 183mm x 43mm
- Gewicht: 1451g
- ISBN-13: 9781498729413
- ISBN-10: 149872941X
- Artikelnr.: 52459404
- Verlag: Taylor & Francis Ltd (Sales)
- 3rd edition
- Seitenzahl: 736
- Erscheinungstermin: 16. März 2018
- Englisch
- Abmessung: 254mm x 183mm x 43mm
- Gewicht: 1451g
- ISBN-13: 9781498729413
- ISBN-10: 149872941X
- Artikelnr.: 52459404
Ron Liu is CEO of AustarPharma, a pharmaceutical company based in Edison, New Jersey.
Introduction. Solubility Theory. Prediction of Solubility. Preformulation Aspects of Insoluble Compounds. Water-Insoluble Drugs and Their Pharmacokinetic Behaviors. Regulatory Aspects of Dissolution for Low Solubility Drug Products. Formulation Strategies and Practice Used for Drug Candidates with Water-Insoluble Properties for Toxicology, Biology, and Pharmacology Studies in Discovery Support. Application of Complexation in Drug Development for Insoluble Compounds. Solubilization Using Cosolvent Approach. Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery
Part I: Parenteral Applications. Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery
Part II: Oral Applications. Micellization and Drug Solubility Enhancement. Polymeric Micelles in Water-Insoluble Drug Delivery. Liposomes in Solubilization. Pharmaceutical Salts. Prodrugs for Improved Solubility in Water. Particle Size Reduction. Development of Solid Dispersion for Poorly Water-Soluble Drugs. Alteration of the Solid State of the Drug Substances: Polymorphs, Solvates, and Amorphous Forms. Pharmaceutical Powder Technology
ICH Q8 and Building the Pyramid of Knowledge. Soft Gelatin Capsules Development. Oral Modified-Release Drug Delivery for Water-Insoluble Drugs. Scalable Manufacturing of Water-Insoluble Drug Products. Index.
Part I: Parenteral Applications. Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery
Part II: Oral Applications. Micellization and Drug Solubility Enhancement. Polymeric Micelles in Water-Insoluble Drug Delivery. Liposomes in Solubilization. Pharmaceutical Salts. Prodrugs for Improved Solubility in Water. Particle Size Reduction. Development of Solid Dispersion for Poorly Water-Soluble Drugs. Alteration of the Solid State of the Drug Substances: Polymorphs, Solvates, and Amorphous Forms. Pharmaceutical Powder Technology
ICH Q8 and Building the Pyramid of Knowledge. Soft Gelatin Capsules Development. Oral Modified-Release Drug Delivery for Water-Insoluble Drugs. Scalable Manufacturing of Water-Insoluble Drug Products. Index.
Introduction. Solubility Theory. Prediction of Solubility. Preformulation Aspects of Insoluble Compounds. Water-Insoluble Drugs and Their Pharmacokinetic Behaviors. Regulatory Aspects of Dissolution for Low Solubility Drug Products. Formulation Strategies and Practice Used for Drug Candidates with Water-Insoluble Properties for Toxicology, Biology, and Pharmacology Studies in Discovery Support. Application of Complexation in Drug Development for Insoluble Compounds. Solubilization Using Cosolvent Approach. Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery
Part I: Parenteral Applications. Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery
Part II: Oral Applications. Micellization and Drug Solubility Enhancement. Polymeric Micelles in Water-Insoluble Drug Delivery. Liposomes in Solubilization. Pharmaceutical Salts. Prodrugs for Improved Solubility in Water. Particle Size Reduction. Development of Solid Dispersion for Poorly Water-Soluble Drugs. Alteration of the Solid State of the Drug Substances: Polymorphs, Solvates, and Amorphous Forms. Pharmaceutical Powder Technology
ICH Q8 and Building the Pyramid of Knowledge. Soft Gelatin Capsules Development. Oral Modified-Release Drug Delivery for Water-Insoluble Drugs. Scalable Manufacturing of Water-Insoluble Drug Products. Index.
Part I: Parenteral Applications. Emulsions, Microemulsions, and Lipid-Based Drug Delivery Systems for Drug Solubilization and Delivery
Part II: Oral Applications. Micellization and Drug Solubility Enhancement. Polymeric Micelles in Water-Insoluble Drug Delivery. Liposomes in Solubilization. Pharmaceutical Salts. Prodrugs for Improved Solubility in Water. Particle Size Reduction. Development of Solid Dispersion for Poorly Water-Soluble Drugs. Alteration of the Solid State of the Drug Substances: Polymorphs, Solvates, and Amorphous Forms. Pharmaceutical Powder Technology
ICH Q8 and Building the Pyramid of Knowledge. Soft Gelatin Capsules Development. Oral Modified-Release Drug Delivery for Water-Insoluble Drugs. Scalable Manufacturing of Water-Insoluble Drug Products. Index.